Tarsus Pharmaceuticals In...

NASDAQ: TARS · Real-Time Price · USD
54.19
0.05 (0.09%)
At close: Aug 15, 2025, 3:59 PM
54.49
0.56%
After-hours: Aug 15, 2025, 06:30 PM EDT

Tarsus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-20.34M -25.12M -23.11M -23.42M -33.29M -35.73M -41.9M -39.15M -31.42M -23.42M -13.6M -22.51M -5.74M -20.24M -14.85M -15.7M 6.34M 10.38M
Depreciation & Amortization
453K 460K 432K 284K 239K 270K 347K 244K 182K 104K 98K 94K 92K 41K 40K 83K 125K 64K
Stock-Based Compensation
8.23M 6.93M 7.4M 7.42M 7.48M 5.52M 5.48M 5.25M 5.19M 3.91M 3.67M 3.58M 3.53M 2.67M 2.18M 2.12M 2.79M 1.36M
Other Working Capital
n/a 2.96M -3.25M -7.47M 3.34M -6.35M 3.56M 968K 206K 3.55M 417K -1.28M -607K -321K -320K 21.27M 190.45M 181.33M
Other Non-Cash Items
-17.73M -2.92M -1.18M 8.73M 914K 9.04M -1.91M 226K 226K -1.15M -1.12M 211K 571K 606K 116K 91K 44K 5.54M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 1.46M -339K -1.12M n/a -5K n/a n/a n/a 358K 350K 903K 35K
Change in Working Capital
n/a n/a -5.73M -1.66M 10.25M -8.59M -2.81M 1.41M 3.12M -1.41M 85K 44K -2.71M 1.63M 37K 20.17M 10.34M -29.17M
Operating Cash Flow
-29.39M -20.65M -22.18M -8.65M -14.4M -37.79M -39.34M -32.36M -23.83M -21.97M -10.87M -18.61M -4.26M -15.29M -12.12M 7.11M 20.55M -11.79M
Capital Expenditures
-1M -590K -5.07M -282K -1.04M -174K 4M -4.38M -787K -340K -127K -96K -122K -161K -274K -121K -16K -175K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 7.63M 4M n/a -11.63M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-129.7M -125.57M -89.97M -24.09M -47.03M -104.55M n/a 3K n/a -28.67M -92.41M -57.03M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
79M 91.22M 35.47M 24.5M 10.54M 2.5M 17.85M 51.74M 64.88M 40.3M 5.32K n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -5M 3M -3M -102.05M -11.63M -4M 64.88M 11.63M 5.31M -57.03M n/a n/a 274K n/a n/a n/a
Investing Cash Flow
-51.7M -34.94M -59.57M 3.13M -40.52M -102.22M 17.85M 47.37M 64.09M 11.29M -87.22M -57.13M -122K -161K -274K -121K -16K -175K
Debt Repayment
n/a n/a n/a n/a 75M n/a n/a 5M n/a 5M n/a n/a n/a 20M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a -6.68M n/a n/a n/a n/a n/a n/a -136K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.31M 136.56M n/a 682K -35.36M 802K 538K 99.89M 510K 13K 264K n/a 74.73M -875K -74K 75K 1K 19K
Financial Cash Flow
1.95M 136.56M 2.93M 639K 42.32M 108.77M 19.76M 104.89M 510K 5.01M 264K -136K 74.73M 19.13M -74K 75K 1K 19K
Net Cash Flow
-79.14M 80.97M -78.83M -4.88M -12.61M -31.24M -1.73M 119.9M 40.78M -5.66M -97.83M -75.87M 70.35M 3.68M -12.47M 7.07M 20.54M -11.95M
Free Cash Flow
-30.39M -21.24M -27.25M -8.93M -15.44M -37.96M -35.34M -36.74M -24.61M -22.31M -11M -18.71M -4.38M -15.45M -12.39M 6.99M 20.54M -11.97M